- Home
- SMTI vs DMAC Comparison
SMTI vs DMAC Comparison
Compare SMTI & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- DMAC
- Stock Information
- Founded
- SMTI 1982
- DMAC 2000
- Country
- SMTI United States
- DMAC United States
- Employees
- SMTI N/A
- DMAC N/A
- Industry
- SMTI Medical/Dental Instruments
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- SMTI Health Care
- DMAC Health Care
- Exchange
- SMTI Nasdaq
- DMAC Nasdaq
- Market Cap
- SMTI 288.2M
- DMAC 267.7M
- IPO Year
- SMTI N/A
- DMAC N/A
- Fundamental
- Price
- SMTI $32.39
- DMAC $5.77
- Analyst Decision
- SMTI Strong Buy
- DMAC Strong Buy
- Analyst Count
- SMTI 2
- DMAC 3
- Target Price
- SMTI $47.00
- DMAC $7.00
- AVG Volume (30 Days)
- SMTI 22.3K
- DMAC 92.0K
- Earning Date
- SMTI 05-12-2025
- DMAC 05-07-2025
- Dividend Yield
- SMTI N/A
- DMAC N/A
- EPS Growth
- SMTI N/A
- DMAC N/A
- EPS
- SMTI N/A
- DMAC N/A
- Revenue
- SMTI $78,056,873.00
- DMAC N/A
- Revenue This Year
- SMTI $35.26
- DMAC N/A
- Revenue Next Year
- SMTI $20.79
- DMAC N/A
- P/E Ratio
- SMTI N/A
- DMAC N/A
- Revenue Growth
- SMTI 24.66
- DMAC N/A
- 52 Week Low
- SMTI $26.00
- DMAC $2.14
- 52 Week High
- SMTI $39.08
- DMAC $6.82
- Technical
- Relative Strength Index (RSI)
- SMTI 44.91
- DMAC 45.29
- Support Level
- SMTI $30.81
- DMAC $5.29
- Resistance Level
- SMTI $32.90
- DMAC $5.90
- Average True Range (ATR)
- SMTI 1.55
- DMAC 0.29
- MACD
- SMTI -0.19
- DMAC -0.08
- Stochastic Oscillator
- SMTI 30.99
- DMAC 38.04
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.